Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for immunotherapy of cancer. Alligator discovers and develops drug development candidates up to phase IIa clinical studies. Alligator’s pipeline currently counts three immune-modulating projects, ADC-1013, ADC-1015, and ADC-1016. Alligator uses its proprietary technology platforms: ALLIGATOR-GOLD, a unique fully human antibody library, and FIND® (Fragment INduced Diversity), a powerful in vitro based antibody optimization technology, in growing our pipeline.

BioInvent is a research-based pharmaceutical company developing innovative antibody drugs targeting cancers with unmet clinical need.Our drug development programmes are supported by our human antibody development platform. This consists of a proprietary antibody library, n-CoDeR:registered:, and in-house technology for the rapid selection, screening and identification of antibodies with excellent affinity and selectivity for targets. BioInvent has a high level of competence in antibody drug discovery, preclinical and clinical development. The Company also has many years' experience in process development and antibody manufacturing, which we carry out at our own facilities. Alongside our in house and partnered drug-development programmes we offer antibody discovery and development services to customers. BioInvent's business model and technology platform have been validated through numerous partnerships. These include a co-development agreement with Bayer, Daiichi Sankyo, Mitsubishi Tanabe, Servier and others. BioInvent employs around 50 people and is based in Lund, Sweden. The Company listed on the NASDAQ OMX Stockholm in 2001.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Shanghai Academy of Agricultural Science is a private company headquartered in Shanghai, China, that provides agricultural research services.

Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.

Phylos, Inc. provides biopharmaceutical research and manufacturing services. The company is headquartered in Lexington, MA.

Tianjin Yaochen Industrial Development Co., Ltd., established on 2014-04-08, The business scope includes instrumentation,electronic product,laboratory equipment,Environmental protection equipment manufacturing,Network technology development,Technology development of computer software, hardware and auxiliary equipment,Sales,software development,Business Consulting,commercial service,Landscaping project,computer network engineering,Municipal Road Engineering,Interior decoration project,Building intelligent installation engineering,building engineering,Landscape Engineering Design,construction,Warehousing Services,Enterprise Marketing Planning.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Sequenom (NASDAQ: SQNM) is an American company based in San Diego, California. It develops enabling molecular technologies, and highly sensitive laboratory genetic tests for NIPT. Sequenom's wholly owned subsidiarity, Sequenom Center for Molecular Medicine (SCMM), offers multiple clinical molecular genetics tests to patients, including MaterniT21, plus a noninvasive prenatal test for trisomy 21, trisomy 18, and trisomy 13, and the SensiGene RHD Fetal RHD genotyping test.

Biométhodes SA develops a technology in engineering and optimization of enzymes. It offers chemical pretreatment of non-food biomass and bio-refinery process. The company was founded in 1997 and is headquartered in Evry, France.

Proteus is a team of passionate techies and business people who tell the truth and do what’s right rather than what is acceptable. They believe adventure, creativity and open-mindedness are key in bringing to life software products that are changing the world. They know there is no substitute for hard work and hustle and always bring 110% as they strive to exceed all their commitments. They know that alone is a lonely road and that no one wins by themselves, but as a team, collaboratively they all succeed. They believe that building candid, open and honest relationships with their clients brings us closer to their human destinies... ...They are convinced that the Platform-as-a-Service (PaaS) spirit with it's nod to dynamic product iteration is at the core of how they positively impact their world.

Nuevolution A/S engages in research and experimental development on biotechnology. It produces and commercializes technologies for the manufacture of substances for use in the pharmaceutical industry by screening non-biological polymers and low-molecular substances. The company was founded on May 8, 2001 and is headquartered in Copenhagen, Denmark.

Shanghai Berger Medical Technology Co., Ltd., established on 2017-03-01, Business scope includes licensed projects:Production of Class III Medical Devices;Class III medical device business;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Instrument sales;Health Consulting Services(Does not include medical services);Data processing and storage support services;Conference and Exhibition Services;Auto New Car Sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Part of Dyadic International, Inc., Dyadic International (USA), Inc. is a company headquartered in Jupiter, FL, involved in biological products, except diagnostic substances. Mark A. Emalfarb is the current CEO of the firm.

BL Corp. engages in the development of biopharmaceutical products. The company operates through the following business divisions: Bio-New Treatment and Product. Its products include poly-y-glutamic acid, lactobacillus plantarum BLS41, and skincare products. The company was founded on December 30, 1999 and is headquartered in Yongin-si, South Korea.

Amicogen, Inc. engages in the development and sale of enzyme products and functional food materials. Its products include specialty enzyme for pharmaceutical, food, feed, and industrial; new bio-ingredients such as natural health ingredients for food, feed and cosmetics; and immunological products such as protein A resin. The company was founded on May 29, 2000 and is headquartered in Jinju-si, South Korea.

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Wuxi Tianyan Biotechnology Co., Ltd., established on 2009-08-17, Business scope includes research and development of biological products,Technical Services,technology transfer,technical consulting;Biochemical preparations and consumables(Free of Hazardous Chemicals)research and development,Sales,Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany.